These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7005747

  • 1. [The use of methylprednisolone in the therapy of renal transplants from cadavers].
    Selva S, Vallino F, Elli A, Trazzi R.
    Minerva Chir; 1980 Oct 31; 35(20):1581-8. PubMed ID: 7005747
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of corticosteroid therapy for acute renal allograft rejection.
    Vineyard GC, Fadem SZ, Dmochowski J, Carpenter CB, Wilson RE.
    Surg Gynecol Obstet; 1974 Feb 31; 138(2):225-9. PubMed ID: 4589909
    [No Abstract] [Full Text] [Related]

  • 3. [The use of high doses of soluble Urbason in the treatment of renal transplants].
    Cucchiara G, Alfani D, Antonacci V, Berloco P, Famulari A, Sturniolo A, Rizzo F.
    Minerva Med; 1980 Feb 11; 71(4):269-72. PubMed ID: 6986588
    [No Abstract] [Full Text] [Related]

  • 4. Steroid treatment for routine immunosuppression in cadaver renal transplantation. A survey of hospitals.
    Kumar P, Leech SH, Gonzalez FM, Kodlin D.
    Proc Clin Dial Transplant Forum; 1980 Feb 11; 8():90-2. PubMed ID: 386327
    [Abstract] [Full Text] [Related]

  • 5. Advantage of long-term alternate day steroid therapy in renal transplantation: a controlled study.
    Dumler F, Levin NW, Szego G, Vulpetti AT, Preuss LE.
    Proc Clin Dial Transplant Forum; 1980 Feb 11; 10():215-9. PubMed ID: 6810344
    [No Abstract] [Full Text] [Related]

  • 6. Lymphoid resistant responses to in vitro immunosuppression in renal transplant recipients: increased incidence of refractory episodes.
    Bowes LG, Dumble LJ, Clunie GJ, Francis DM, Macdonald IM, Kincaid-Smith P.
    Transplant Proc; 1988 Feb 11; 20(1):20-2. PubMed ID: 2964112
    [No Abstract] [Full Text] [Related]

  • 7. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S, Alexander JW, Schroeder TJ, First MR.
    Clin Transplant; 1996 Dec 11; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [Abstract] [Full Text] [Related]

  • 8. Skin and renal rabbit allograft rejection following large pulse doses of methylprednisolone.
    Friedman EA, Beyer MM.
    Transplant Proc; 1975 Mar 11; 7(1):67-72. PubMed ID: 1091047
    [No Abstract] [Full Text] [Related]

  • 9. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.
    Burleson RL, Jones DB, Yenikomshian A, DeVoe C, DeRito J.
    Transplant Proc; 1977 Sep 11; 9(3):1591-6. PubMed ID: 331594
    [Abstract] [Full Text] [Related]

  • 10. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
    Fukuhara N, Ono Y, Hattori R, Nishiyama N, Yamada S, Kamihira O, Kinukawa T, Ohshima S.
    Clin Transplant; 2005 Apr 11; 19(2):153-7. PubMed ID: 15740548
    [Abstract] [Full Text] [Related]

  • 11. Intravenous methylprednisolone at the time of renal transplantation.
    Heaton A, Wilkinson R, Elliott RW, Ward MK, Taylor RM, Proud G.
    Proc Eur Dial Transplant Assoc; 1983 Apr 11; 19():482-7. PubMed ID: 6348749
    [Abstract] [Full Text] [Related]

  • 12. Effects of intravenous bolus dosages of methylprednisolone and local radiation on renal allograft rejection and patient mortality.
    Nakajima N, Sreepada Rao TK, Sakai A, Butt KH, Kountz SL.
    Surg Gynecol Obstet; 1977 Jan 11; 144(1):63-6. PubMed ID: 318773
    [Abstract] [Full Text] [Related]

  • 13. Treatment of steroid resistant acute rejection after renal transplantation.
    Oh CK, Kim YS, Kim MS, Kim SI, Park K.
    Transplant Proc; 1996 Jun 11; 28(3):1453-4. PubMed ID: 8658737
    [No Abstract] [Full Text] [Related]

  • 14. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R.
    Clin Transplant; 1996 Apr 11; 10(2):209-12. PubMed ID: 8664521
    [Abstract] [Full Text] [Related]

  • 15. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H, Haussman G, Isaacs I, Ishitani M, Lobo P, McCullough C, Pruett T.
    Clin Transplant; 1997 Oct 11; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [Abstract] [Full Text] [Related]

  • 16. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S, Hayashi R, Niiya S, Kenmochi T, Fukuoka T, Amemiya H.
    Transplant Proc; 1991 Feb 11; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of kidney-graft rejection with high doses of methylprednisolone].
    Kaslíková J, Jirka J, Reneltová I, Kocandrle V.
    Vnitr Lek; 1977 Jun 11; 23(6):540-3. PubMed ID: 329567
    [No Abstract] [Full Text] [Related]

  • 18. Suppressor factor in plasma of aminophylline treated renal transplanted patients.
    Shapira Z, Shohat B, Yusim A, Servadio C.
    Proc Eur Dial Transplant Assoc; 1983 Jun 11; 19():473-6. PubMed ID: 6224211
    [Abstract] [Full Text] [Related]

  • 19. Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects.
    Elli A, Rivolta R, Palazzi P, Mascaretti L, Puglisi G, Parenti M, Sioli V, Di Palo FQ.
    Transplant Proc; 1990 Aug 11; 22(4):1689-90. PubMed ID: 2202126
    [No Abstract] [Full Text] [Related]

  • 20. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E, Alfani D, Monari C, Trovati A, Berloco P, Famulari A, Cucchiara G, Cortesini R.
    Minerva Chir; 1980 May 31; 35(10):747-50. PubMed ID: 7005730
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.